शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSESYSCHEM (INDIA) LTD.· Pharmaceuticals & BiotechnologyMediumNeutral
Announced Tue, 27 Oct, 2026 · 15:36 IST

Q2 FY26-27 profit rebounds as revenue and operating earnings improve

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.7%Reaction day
₹35.90
prior close
₹36.99
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+2.6% vs market
Pharmaceuticals peers, median of 170sector+0.6%+2.1% vs sector

On the reaction day the stock moved 2.6 pts more than Nifty Microcap 250 and 2.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-4.1
10m
-4.1
15m
+1.3
30m
+1.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.7+0.1+2.6+0.6+2.1
Next day
-0.4+0.7-1.2+1.1-1.6
2d
-7.4-1.8-5.6-0.1-7.3
3d
-9.1-0.4-8.8+0.2-9.3
4d
-4.6-0.1-4.5+0.4-5.1
5d
-6.7+2.1-8.8+1.5-8.2
1w
-12.0pendingpending+2.2-14.2
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Syschem India returned to profit in Q2 FY26-27. Revenue rose 3% to Rs 12,979 lakh from Rs 12,599 lakh in Q1 and was above Rs 11,793 lakh a year earlier. EBITDA rose to Rs 466 lakh from Rs 59 lakh, profit before tax reached Rs 212.94 lakh versus a Rs 145 lakh loss, and net profit was about Rs 190 lakh.

Likely market impact

Positive for shareholders as earnings recovered, but weak demand, higher input costs and currency volatility may limit how durable the turnaround is.